Portfolio Drug Substance USA

Portfolio Drug Substance USA
Therapeutic Areas
Monographs
Regulatory
Documentation
Scheduled
Status
CAS Number
Amobarbital Sodium
Anticonvulsant, sedative
USP
USDMF
II
64-43-7
Buprenorphine Base Analgesic (opioid addiction)
USP / PHEUR
CEP
IIIN
52485-79-7
Buprenorphine HCl
Analgesic (opioid addiction)
USP / PHEUR
USDMF / CEP
IIIN
53152-21-9
Butalbital Base
Sedative
USP
USDMF
III
77-26-9
Codeine Phosphate
Analgesic, antitussive
USP / PHEUR
USDMF / CEP
II
41444-62-6
List Products
1
Dexmethylphenidate HCl
CNS stimulant
USP
USDMF
II
19262-68-1
Hydrocodone Bitartrate 2
Analgesic, antitussive
USP
USDMF
II
34195-34-1
Hydromorphone HCl
Analgesic
USP / PHEUR
USDMF / CEP
II
71-68-1
Methadone HCl
Analgesic, opioid addiction
USP / PHEUR
USDMF / CEP
II
1095-90-5
Methylphenidate Base
CNS stimulant
USP
USDMF
II
113-45-1
Methylphenidate HCI
CNS stimulant
USP
USDMF
II
298-59-9
Morphine Sulfate
Analgesic
USP / PHEUR
USDMF / CEP
II
6211-15-0
Naloxone HCl
Opiate antagonist
USP / PHEUR
CEP filed / USDMF
n.a.
357-08-4
Opiate antagonist
USP / PHEUR
USDMF / CEP
n.a.
16676-29-2
Oxycodone HCl Analgesic
USP / PHEUR
USDMF / CEP
II
124-90-3
Oxymorphone HCl
Analgesic
USP
USDMF
II
357-07-3
Pentobarbital Sodium
Veterinary euthanasia,
human sedative
USP
USDMF
II
57-33-0
Phenobarbital Sodium
Sedative, anticonvulsant, hypnotic
USP
USDMF
IV
57-30-7
Phentermine Base
Anorexic
–
USDMF
IV
122-09-8
Phentermine HCl
Anorexic
USP
USDMF
IV
1197-21-3
Primidone
Anticonvulsant
USP / PHEUR
USDMF / CEP
n.a.
125-33-7
Secobarbital Sodium
Sedative
USP
USDMF
II
309-43-3
Trimethobenzamide HCl
Antiemetic
USP
USDMF
n.a.
554-92-7
Naltrexone HCl
2
1
2
Commercial in EU, Development in US
Low ABUK impurity grade material
Development Products
Therapeutic Areas
Commercial
Availability
Monographs
Regulatory
Documentation
Packaging
(kg)
CAS Number
Naltrexone Base
Opiate antagonist
Yes 3
USP / PHEUR
In development
n.a.
16590-41-3
Methadone Base
Analgesic, opioid addiction
Yes USP / PHEUR
In development
n.a.
76-99-3
Methylnaltrexone Bromide
Opiate antagonist
On request
n.a.
In development
n.a.
83387-25-1
Tapentadol
Analgesic
On request
n.a.
In development
n.a.
175591-23-8
3
3
Clinical Trial Material
Any product descriptions, or services noted on this portfolio list are not intended to constitute offers to sell or solicitations in connection with any products or services.
This portfolio list may provide information for products and services that are not available in all jurisdictions.
Siegfried USA, LLC
33 Industrial Park Rd
Pennsville
NJ 08070
Phone +1 877 763 8630
Fax +1 856 678 8201
[email protected]
www.siegfried.ch
© Siegfried AG, October 2013